Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of U.S. Physical Therapy, Inc. (NYSE:USPH). In a filing disclosed on February 11th, the Representative disclosed that they had bought between $1,001 and $15,000 in U.S. Physical Therapy stock on January 29th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of ICF International NASDAQ: ICFI on 2/3/2025.
- Purchased $15,001 - $50,000 in shares of CACI International NYSE: CACI on 1/31/2025.
- Purchased $50,001 - $100,000 in shares of Hawaiian Electric Industries NYSE: HE on 1/31/2025.
- Sold $1,001 - $15,000 in shares of Broadcom NASDAQ: AVGO on 1/30/2025.
- Purchased $1,001 - $15,000 in shares of Intuitive Surgical NASDAQ: ISRG on 1/30/2025.
- Purchased $1,001 - $15,000 in shares of Agios Pharmaceuticals NASDAQ: AGIO on 1/29/2025.
- Purchased $1,001 - $15,000 in shares of SpringWorks Therapeutics NASDAQ: SWTX on 1/29/2025.
- Purchased $1,001 - $15,000 in shares of Paragon 28 NYSE: FNA on 1/29/2025.
- Purchased $1,001 - $15,000 in shares of Crinetics Pharmaceuticals NASDAQ: CRNX on 1/29/2025.
- Purchased $1,001 - $15,000 in shares of Lantheus NASDAQ: LNTH on 1/28/2025.
U.S. Physical Therapy Price Performance
USPH traded up $0.35 on Friday, hitting $86.85. 77,568 shares of the company were exchanged, compared to its average volume of 82,825. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The business's fifty day moving average is $89.88 and its 200 day moving average is $87.94. U.S. Physical Therapy, Inc. has a fifty-two week low of $76.18 and a fifty-two week high of $113.63. The firm has a market capitalization of $1.31 billion, a P/E ratio of 92.39, a price-to-earnings-growth ratio of 3.61 and a beta of 1.48.
Insider Buying and Selling at U.S. Physical Therapy
In other news, CFO Carey P. Hendrickson sold 516 shares of the firm's stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $96.25, for a total value of $49,665.00. Following the transaction, the chief financial officer now directly owns 20,469 shares in the company, valued at approximately $1,970,141.25. This trade represents a 2.46 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.70% of the stock is currently owned by insiders.
Institutional Investors Weigh In On U.S. Physical Therapy
A number of large investors have recently added to or reduced their stakes in USPH. Bahl & Gaynor Inc. grew its holdings in U.S. Physical Therapy by 135.4% during the 4th quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company's stock valued at $23,076,000 after purchasing an additional 149,622 shares in the last quarter. State Street Corp grew its holdings in U.S. Physical Therapy by 17.5% during the 3rd quarter. State Street Corp now owns 667,868 shares of the company's stock valued at $56,522,000 after purchasing an additional 99,244 shares in the last quarter. Copeland Capital Management LLC grew its holdings in U.S. Physical Therapy by 9.5% during the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock valued at $74,459,000 after purchasing an additional 72,715 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in U.S. Physical Therapy during the 4th quarter valued at $6,240,000. Finally, Southernsun Asset Management LLC boosted its stake in U.S. Physical Therapy by 10.5% during the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company's stock valued at $46,302,000 after acquiring an additional 52,062 shares during the last quarter.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on the stock. Bank of America raised shares of U.S. Physical Therapy from a "neutral" rating to a "buy" rating and upped their price objective for the company from $100.00 to $115.00 in a research note on Monday, December 16th. JMP Securities began coverage on shares of U.S. Physical Therapy in a research note on Monday, December 16th. They set an "outperform" rating and a $113.00 price objective on the stock. Citizens Jmp raised shares of U.S. Physical Therapy to a "strong-buy" rating in a research report on Monday, December 16th. Barrington Research reaffirmed an "outperform" rating and set a $108.00 price target on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. Finally, JPMorgan Chase & Co. upped their price target on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an "overweight" rating in a research report on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average price target of $114.00.
View Our Latest Analysis on U.S. Physical Therapy
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
About U.S. Physical Therapy
(
Get Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
See Also
Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
